Literature DB >> 21635566

Contribution of the P2X7 1513A/C loss-of-function polymorphism to extrapulmonary tuberculosis susceptibility in Tunisian populations.

Walid Ben-Selma1, Imen Ben-Kahla, Jalel Boukadida, Hedi Harizi.   

Abstract

The P2X7 receptor has been found to be linked to an increased risk for tuberculosis in some populations. In this study, we investigate whether the P2X7 receptor plays a role in increasing susceptibility to tuberculosis in Tunisia. We examined two 1513A/C and -762T/C polymorphisms at the P2X7 receptor in 168 patients with pulmonary TB (pTB), 55 patients with extrapulmonary TB (epTB) and 150 blood donors from Tunisia. Genotyping of 1513A/C and -762T/C polymorphisms was performed in purified genomic DNA using PCR-restriction fragment length polymorphism and allele-specific PCR, respectively. The 1513C, CC and AC loss-of-function allele and genotypes were overrepresented in the epTB group compared with the control group (45% vs. 17%, P=10(-8) ; 24% vs. 4%, P=3 × 10(-7) ; 42% vs. 27%, P=10(-3) , respectively). Additionally, they were associated with 3.83-, 11.86- and 3.15-fold risks of developing this clinical tuberculosis form, respectively. No associations between the -762T/C polymorphism and tuberculosis disease, as well as disease anatomic location were observed. Collectively, our results suggest that the P2X7 1513A/C loss-of-function polymorphism may contribute to susceptibility to epTB in Tunisian populations.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21635566     DOI: 10.1111/j.1574-695X.2011.00824.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  8 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

2.  The association between C-159T polymorphism in CD14 gene and susceptibility to tuberculosis: a meta-analysis.

Authors:  Qing Yuan; Huifang Chen; Xueyan Zheng; Xiaming Chen; Qun Li; Yanping Zhang; Xiaorong Zhang; Tingli Shi; Junhua Zhou; Qing Chen; Shouyi Yu
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

3.  A meta-analysis of P2X7 gene-762T/C polymorphism and pulmonary tuberculosis susceptibility.

Authors:  Lingling Yi; Dan Cheng; Huimin Shi; Xiaorong Huo; Kan Zhang; Guohua Zhen
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

4.  P2X71513 A>C Polymorphism Confers Increased Risk of Extrapulmonary Tuberculosis: A Meta-analysis of Case-Control Studies.

Authors:  Mohammed Y Areeshi; Raju K Mandal; Sajad Dar; Mohd Wahid; Md Ekhlaque A Khan; Aditya K Panda; Arshad Jawed; Shafiul Haque
Journal:  Curr Genomics       Date:  2015-10       Impact factor: 2.236

Review 5.  Purinergic Signaling: A Common Path in the Macrophage Response against Mycobacterium tuberculosis and Toxoplasma gondii.

Authors:  Laetitia Petit-Jentreau; Ludovic Tailleux; Janine L Coombes
Journal:  Front Cell Infect Microbiol       Date:  2017-08-07       Impact factor: 5.293

Review 6.  The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

Authors:  Luiz E B Savio; Paola de Andrade Mello; Cleide Gonçalves da Silva; Robson Coutinho-Silva
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

7.  Polymorphisms in the P2X7 receptor, and differential expression of Toll-like receptor-mediated cytokines and defensins, in a Canadian Indigenous group.

Authors:  Catlin Semple; Ka-Yee Grace Choi; Andrea Kroeker; Lizette Denechezhe; Pamela Orr; Neeloffer Mookherjee; Linda Larcombe
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

8.  The -2518A/G polymorphism in the MCP-1 gene and tuberculosis risk: a meta-analysis.

Authors:  Yonggang Zhang; Jie Zhang; Lingjun Zeng; Honglang Huang; Min Yang; Xiaowei Fu; Can Tian; Zhangpeng Xiang; Jin Huang; Hong Fan
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.